STOCK TITAN

agilon health, inc. - AGL STOCK NEWS

Welcome to our dedicated page for agilon health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on agilon health stock.

agilon health, inc. (NYSE: AGL) is a transformative health care partner dedicated to redefining primary care by enabling physicians with the tools, technology, and support needed to deliver high-quality care. agilon health forms strategic long-term partnerships with physician groups to transition them to a value-based care model, aiming to improve patient outcomes while reducing costs. The company operates a purpose-built platform that supports over 3,000 primary care physicians (PCPs) across more than 30 communities, providing care to over 700,000 senior patients.

agilon health’s core business revolves around empowering physicians to create a Medicare-centric, globally capitated line of business. The company derives its revenue from providing medical services under full-risk contracts, which aligns financial incentives with patient health outcomes. agilon health has demonstrated significant growth, achieving a 75% increase in revenue to $1.22 billion, with Medicare Advantage membership surging by 58% to 420,300 members.

The company's recent achievements include the publication of a peer-reviewed study on its value-based palliative care program, showcasing improved patient-centered outcomes. Additionally, agilon health has successfully expanded its Physician Network with new partnerships in Kentucky, Minnesota, Illinois, and North Carolina, further solidifying its presence in the U.S. healthcare market.

Financially, agilon health has shown resilience and adaptability. Despite challenges, the company has maintained strong revenue growth and continues to make progress in executing its targeted action plans to drive profitability and enhance operational efficiency. agilon health’s balance sheet reflects a solid financial position, with significant cash reserves and manageable debt levels, positioning the company for sustained growth and long-term success.

agilon health stands out in the healthcare sector by focusing on a value-based care model that prioritizes patient health over service volume. This approach not only benefits patients but also supports physicians in maintaining their independence and achieving better health outcomes for their patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
none
-
Rhea-AI Summary

agilon health, inc. (NYSE: AGL) will participate in the 41st Annual J.P. Morgan Healthcare Conference with a fireside chat on January 9 at 12:45 PM Eastern Time. Investors can access a live webcast of the presentation on agilon's investor relations website. A replay will be available shortly after the event. agilon health partners with physician groups to transition to a value-based Total Care Model, aiming to enhance healthcare for senior patients. Currently, agilon operates in 17 diverse communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
conferences
-
Rhea-AI Summary

agilon health, inc. (NYSE: AGL) will participate in the 4th Annual Wolfe Research Healthcare Conference, featuring a fireside chat presentation on November 17 at 1:20 PM ET. Investors can access the live webcast through the 'Events & Presentations' section on agilon health's investor relations website. A replay will be available post-event. Agilon health partners with physician groups to enhance healthcare delivery through value-based models, supporting senior patients in 17 communities. For more information, visit www.agilonhealth.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
conferences
Rhea-AI Summary

Agilon Health, Inc. (NYSE: AGL) reported a 52% revenue increase to $695 million for Q3 2022, compared to $459 million in Q3 2021. Total membership grew 45% to 266,600 Medicare Advantage members, with total members on the platform reaching 356,000. The medical margin surged 74% to $76 million, representing 10.9% of revenue. Adjusted EBITDA improved to $15 million for the first nine months. Despite a net loss of $31 million for Q3, the outlook for FY 2022 reflects continued membership and revenue growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.31%
Tags
none
-
Rhea-AI Summary

agilon health, inc. (NYSE: AGL) will release its Q3 2022 financial results on November 3, 2022, after the market closes. A conference call is scheduled for 5:00 PM ET on the same day, accessible by phone or through a webcast on the company’s Investor Relations site. The event aims to discuss the financial results and provide insights to investors. agilon health focuses on empowering physicians and transitioning to a value-based Total Care Model for senior patients, serving 17 communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.92%
Tags
conferences earnings
-
Rhea-AI Summary

agilon health, inc. (NYSE: AGL) announced its participation in two key investor conferences. The first is the Wells Fargo Healthcare Conference on September 8 at 10:25 AM ET, followed by the Morgan Stanley 20th Annual Global Healthcare Conference on September 14 at 3:30 PM ET. Investors can access live webcasts of these events through the agilon health investor relations website. The company focuses on empowering physicians to enhance healthcare services in communities, transitioning to a value-based Total Care Model for senior patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.97%
Tags
conferences
Rhea-AI Summary

agilon health announces the retirement of Michael Smith from its board of directors after over five years. Jeff Schwaneke, previously Executive VP at Centene Corporation, will join as an independent board member. Schwaneke brings extensive experience including overseeing a $35 billion pharmacy business and a significant growth in revenues at Centene, from $20 billion to $125 billion. The company views this transition as crucial for its growth during an evolving healthcare landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.66%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.66%
Tags
none
-
Rhea-AI Summary

Agilon Health (NYSE: AGL) reported significant financial growth for Q2 2022, with total revenue reaching $670 million, a 34% increase from Q2 2021. Year-to-date, revenue surged 45% to $1.32 billion. Medicare Advantage membership increased by 44%, totaling 261,200 members. The company's medical margin rose 49% to $82 million, reflecting a margin of 12.2% of revenue. Despite a net loss of $21 million, a notable improvement from a $299 million loss last year, Agilon reported an adjusted EBITDA of $7 million, up from negative $2 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
Rhea-AI Summary

agilon health, inc. (NYSE: AGL) will release its financial results for Q2 2022 on August 4, 2022, after market close. A conference call is scheduled for 5:00 PM ET to discuss these results, accessible via (844) 200-6205 for U.S. participants and +1 (646) 904-5544 for international callers, using participant code 043762. The call will also be available as a webcast on agilon's Investor Relations website. agilon health aims to support physician groups transitioning to a value-based care model, creating healthier communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.22%
Tags
conferences earnings

FAQ

What is the current stock price of agilon health (AGL)?

The current stock price of agilon health (AGL) is $1.97 as of December 20, 2024.

What is the market cap of agilon health (AGL)?

The market cap of agilon health (AGL) is approximately 807.6M.

What is agilon health's core business?

agilon health partners with primary care physicians to transition them to a value-based care model, focusing on improving patient outcomes while reducing healthcare costs.

How does agilon health generate revenue?

The company derives its revenue from providing medical services under full-risk contracts, aligning financial incentives with patient health outcomes.

What recent achievements has agilon health accomplished?

Recent achievements include publishing a peer-reviewed study on their palliative care program and expanding their Physician Network with new partnerships in several states.

How is agilon health performing financially?

agilon health has shown strong revenue growth, increasing by 75% to $1.22 billion, and continues to maintain a solid financial position with significant cash reserves and manageable debt levels.

What is agilon health's approach to healthcare?

agilon health focuses on a value-based care model that prioritizes patient health over service volume, benefiting both patients and physicians.

How many physicians are part of agilon health's network?

agilon health's Physician Network includes over 3,000 primary care physicians delivering care to more than 700,000 senior patients.

What is the significance of agilon health's value-based care model?

The value-based care model aims to improve patient outcomes and reduce costs by aligning financial incentives with health outcomes, supporting physicians in maintaining independence and delivering high-quality care.

What challenges has agilon health faced recently?

agilon health faced challenges with higher-than-expected medical costs but has implemented targeted action plans to drive profitability and enhance operational efficiency.

What are agilon health's plans for future growth?

agilon health plans to continue expanding its Physician Network, forming new partnerships, and maintaining its focus on value-based care to drive long-term success.

How does agilon health support its physician partners?

agilon health provides technology, people, capital, and process support to help physician groups focus on delivering comprehensive care and achieving better patient outcomes.

agilon health, inc.

NYSE:AGL

AGL Rankings

AGL Stock Data

807.55M
304.49M
1.79%
105.15%
7.38%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States of America
AUSTIN